Highly unlikely IMU isn't going to do another data cut for Azer-Cel in a month time, likely it will be done H2 of this year around Oct/Nov for the required patients to apply for registrational clinical trial. The expected clinical trial updates this half will be from VAXINIA and OASIS which will be the catalysts for the pps re-rate.
IMU Price at posting:
3.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)